J&J's Remicade Label Adds Hematologic, Neurologic Warnings
This article was originally published in The Pink Sheet Daily
Executive Summary
Competing TNF-inhibitors Enbrel and Humira have similar warnings. The changes to Remicade's label were based on post-marketing adverse event reports.